/Companies

Darmiyan

YC S17

San Francisco, US · Founded 2016 · Delaware corporation · 8 employees · 14 known investors

Find your way into Darmiyan

Sign up to see every warm intro you have to Darmiyan

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Darmiyan team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Darmiyan develops medical AI and brain imaging software for early detection and monitoring of neurodegenerative diseases, particularly Alzheimer's. The platform targets healthcare providers, patients, and pharmaceutical companies seeking to advance brain health and disease prevention.

Founders & leadership· Y Combinator alumni (S17)

Darmiyan was founded in 2016 by Padideh Kamali-Zare and Kaveh Vejdani.

PKPadideh Kamali-Zare
Padideh Kamali-ZareCo-founder · Chief Executive OfficerPadideh Kamali-Zare holds a Ph.D. in Biological Physics from KTH and completed a postdoctoral position in computational neuroscience at NYU. She founded Darmiyan to develop early diagnostic tools for Alzheimer's disease.
KVKaveh Vejdani
Kaveh VejdaniChief Medical and Technology Officer
TL
Thomas LiebmannChief Scientific Officer2014–2024

Board

ST
Shirai TakehiroBoard director

Investors · 14

Baleen Capitalreported

How we know: Y Combinator's founder network · Not right? Tell us

DHVCreportedMenlo Park

How we know: Y Combinator's founder network · Not right? Tell us

Nordron ABreported

How we know: Y Combinator's founder network · Not right? Tell us

OurCrowdreportedJerusalem

How we know: Y Combinator's founder network · Not right? Tell us

Pegasus Tech VenturesreportedSan Jose

How we know: Y Combinator's founder network · Not right? Tell us

Seven Seas PartnersreportedMenlo Park

How we know: Y Combinator's founder network · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$10M disclosed across 2 rounds · 2020–2023

▶$3.5MraisedOct 2023 · 5 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kaveh VejdaniDirector
  • Takehiro ShiraiDirector
  • Padideh Kamali-ZareExecutive Officer
Offering amount
$3.5M
Amount sold
$3.5M
First sale
Oct 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.4MraisedApr 2020 · 32 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Padideh Kamali-ZareExecutive Officer, Director
  • Shirai TakehiroDirector
  • Kaveh VejdaniExecutive Officer, Director
Offering amount
$9.7M
Amount sold
$6.4M
First sale
Mar 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 4

Companies working in the same space as Darmiyan.

Legal entities · 1

corporate structure
Darmiyan, Inc.

In the news

Frequently asked questions

What does Darmiyan do?
Darmiyan develops medical AI and brain imaging software for early detection and monitoring of neurodegenerative diseases, particularly Alzheimer's. The platform targets healthcare providers, patients, and pharmaceutical companies seeking to advance brain health and disease prevention.
Who founded Darmiyan?
Darmiyan was founded by Padideh Kamali-Zare, Kaveh Vejdani in 2016.
Who are Darmiyan's investors?
Darmiyan's investors include AAF Management Ltd., Eisai Innovation, Inc., IT-Farm Corporation, Soma Capital, Y Combinator, Arkitekt Ventures, Baleen Capital, DHVC and 6 more.
How much funding has Darmiyan raised?
Darmiyan has disclosed $10M raised across 2 rounds.
Where is Darmiyan headquartered?
Darmiyan is headquartered in San Francisco, US.